Stock NB3 NEUROCRINE BIOSCIENCES, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Relative Strength Chart Neurocrine Biosciences, Inc. Deutsche Boerse AG

Equities

NB3

US64125C1099

Market Closed - Deutsche Boerse AG
Other stock markets
 17:28:09 31/05/2024 BST 		5-day change 1st Jan Change
124 EUR +0.61% Intraday chart for Neurocrine Biosciences, Inc. -4.36% +4.38%
05-31 Neurocrine Biosciences Insider Sold Shares Worth $5,338,565, According to a Recent SEC Filing MT
05-28 Neurocrine Biosciences Says CEO Kevin Gorman Retiring MT

End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
NEUROCRINE BIOSCIENCES, INC.
Bio Therapeutic Drugs
+0.61%-4.36%+4.38%+48.71%+69.05% 13.63B - - -
  1. Stock Market
  2. Equities
  3. NBIX Stock
  4. NB3 Stock
  5. Charts Neurocrine Biosciences, Inc.
  6. Relative Strength Chart